The addition to intact cells of an inositol phospho-oligosaccharide (POS), which is the polar head-group of an insulin-sensitive glycosylphosphatidylinositol, mimics and may mediate some of the biological effects of this hormone. Here we report the existence of a POS transport system in hepatocytes. This POS transport system is specific and time- and dose-dependent. Insulin-resistance caused by dexamethasone administration to rats was accompanied by a decrease in the hepatocyte POS transport system. In contrast, bilateral adrenalectomy provoked a significant increase in the transport of POS. Both the temporal uptake of POS and the regulation of this process by conditions known to modify the sensitivity to insulin suggest that this novel transport system might be involved in the insulin signalling mechanism.
1 September 2016 in The Journal of Pharmacology and Experimental Therapeutics
Cannabinoid receptors are G-protein-coupled receptors with potential in a variety of diseases. There are two different cannabinoid receptors types; ligands for type 2 (CB2R) show more promise than those for type 1 (CB1R) as they lack psychotropic actions. However, the lipophilic nature of CB2R ligands and the complex pharmacology of these receptors are delaying the translational success of medications targeting the endocannabinoid system. We here report the discovery and synthesis of a fluorophore-labeled high-affinity and CB2R-selective ligand that may be used in nonradioactive binding assays. The novel fluorophore-conjugated compound was useful for pharmacological characterization of CB2R by using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. This methodology does not require radiolabelled compounds and may be undertaken in homogeneous conditions and in living cells. TR-FRET assays disclosed a previously unreported second affinity site and showed conformational changes in CB2R forming receptor heteromers with another G-protein-coupled receptor.